Driven by Dual Engines of AI and New Energy, Han’s Laser Revenue Topped USD 2.67 Billion with Nearly Doubled NPAT (excl. NRGL)

On April 17th, Han’s Laser (002008.SZ) released its 2025 annual report. The report indicates that Han’s Laser exceeded annual ...
Opalesque

Four boutique hedge fund managers on finding Alpha where the crowd isn't looking

Episode 20 of Opalesque's flagship Small Managers - BIG ALPHA webinar series brought together four boutique investment managers who have each found a distinct path to generating alpha independently of ...

ThisWay Global Taps NVIDIA Product Executive Stephan Fabel as CEO to Power Next-Generation Sovereign AI Platform

AUSTIN, TX, UNITED STATES, April 22, 2026 /EINPresswire.com/ -- Veteran technology executive brings deep expertise in ...
eLife

Morphine regulates astrocyte transcriptional dynamics in the ventral tegmental area by stimulation of glucocorticoid signaling

The ventral tegmental area (VTA) is a key site for opioid actions, and emerging evidence suggests that pain states and opioid experience both induce transcriptional, molecular, and circuit adaptations ...
Le Lézard

Nature Reviews Drug Discovery | Target Identification and Assessment in the Era of AI

Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 protein-coding genes, only about 4,500 are ...
Le Lézard

NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs

NetraMark Holdings Inc. (the "Company" or "NetraMark") , a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, ...